Premium
Protamine usage following implantation of drug‐eluting stents: A word of caution
Author(s) -
Cosgrave John,
Qasim Asif,
Latib Azeem,
Aranzulla Tiziana C.,
Colombo Antonio
Publication year - 2008
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.21439
Subject(s) - medicine , protamine , percutaneous , stent , drug , drug eluting stent , surgery , food and drug administration , restenosis , heparin , pharmacology
The treatment of hemorrhagic complications of percutaneous interventions with protamine is an accepted practice. Concerns exist about the increased thrombo‐genicity of drugeluting stents. We report two cases of acute stent thrombosis following drug‐eluting stent implantation related to Protamine administration. © 2008 Wiley‐Liss, Inc.